Combo therapy may prevent cancer’s return after liver surgery. Atezolizumab and bevacizumab are already used together to treat advanced liver cancer, now a new study finds it does the same for early-stage disease. Read more
MONDAY, April 24, 2023 (HealthDay News) — A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.
This is your brain on books: Science unravels the secrets of reading. Recordings of brain activity in 36 people identified two key brain “networks” involved in the task. Read more
MONDAY, April 24, 2023 (HealthDay News) — Reading is fundamental, but it’s also a complex skill. Now, a new study sheds more light on how the brain makes sense of the written word.
Is surgery for sciatica really worth it? In a new study, patients who got the procedure were not better off a year later than those who used other treatments. Read more
People are also reading…
MONDAY, April 24, 2023 (HealthDay News) — Sciatica can send searing, unrelenting pain down your legs, and surgery is often recommended if other less invasive measures fail to bring relief.
How many CT scans are healthy for kids? While a study found no increased risk after one CT scan, children who received two to three scans had an increased risk of intracranial tumors. Read more
MONDAY, April 24, 2023 (HealthDay News) — Getting a single CT scan during childhood doesn’t appear to increase a child’s risk of a future brain tumor, leukemia or lymphoma, new research finds, but getting four or more scans more than doubles the chances.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
